Impact of UPF2 on the levels of CD81 on extracellular vesicles

Front Cell Dev Biol. 2024 Nov 25:12:1469080. doi: 10.3389/fcell.2024.1469080. eCollection 2024.

Abstract

Extracellular vesicles (EVs) are involved in cell-to-cell communication. Following uptake, EV cargo molecules, including DNA, RNA, lipids, and proteins, influence gene expression and molecular signaling in recipient cells. Although various studies have identified disease-specific EV molecules, further research into their biogenesis and secretion mechanisms is needed for clinical application. Here, we investigated the role of UPF2 in regulating the biogenesis and components of EVs. Notably, UPF2 promoted the expression of CD81, a membrane protein marker of EVs, as UPF2 silencing decreased CD81 levels in EVs, both inside the cell and secreted. In contrast, the expression levels of CD63 increased, without altering the size or numbers of EVs. In addition, reducing UPF2 levels did not affect the total number of EVs but lowered production of CD81-positive EVs and reduced the efficiency of uptake by recipient cells. Collectively, our findings uncover a novel function for UPF2 in regulating the production of CD81 and changing EV properties.

Keywords: CD81; EV biogenesis; EV uptake; UPF2; exosomes; extracellular vesicles.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the research fund of Chungnam National University and National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1C1C1010869 to KMK, NRF-2022R1A2C1010973 to JHN), and the Basic Science Research Program through the NRF funded by the Ministry of Education (RS-2023-00242914 to KMK, NRF-2019R1I1A3A01061807 to JHN), and the Bio&Medical Technology Development Program of the NRF funded by the Korean government (MSIT) (RS-2021-NR057006 to JHN). MG and KM-M were funded by grant Z01-AG000511, from the National Institute on Aging Intramural Research Program of the National Institutes of Health.